Inventor · disambiguated record
Sebastien Jeay
Also filed as: JEAY SEBASTIEN
4 granted patents·14 pending applications·15 citations·filing 2005–2024
72Inventor score
Top patents by PatentIndex Score
18 records- 0186US11419870B2Intermittent dosing of MDM2 inhibitorNOVARTIS AG·Filed 2020·Granted Aug 23, 2022·2 cites·4 claims
- 0284US9371568B2Markers associated with human double minute 2 inhibitorsNOVARTIS AG·Filed 2013·Granted Jun 21, 2016·10 cites·3 claims
- 0381US2024261284A1Intermittent dosing of mdm2 inhibitorNOVARTIS AG·Filed 2024·Application pending·0 cites
- 0475US2023092181A1Intermittent dosing of mdm2 inhibitorNOVARTIS AG·Filed 2022·Application pending·0 cites
- 0572US10220038B2Pharmaceutical combinationsNOVARTIS AG·Filed 2018·Granted Mar 5, 2019·1 cites·9 claims
- 0669US10966978B2Dose and regimen for HDM2-p53 interaction inhibitorsNOVARTIS AG·Filed 2017·Granted Apr 6, 2021·2 cites·20 claims
- 0767US2019209561A1Intermittent dosing of mdm2 inhibitorNOVARTIS AG·Filed 2018·Application pending·0 cites
- 0864US2018110779A1Intermittent dosing of mdm2 inhibitorNOVARTIS AG·Filed 2017·Application pending·0 cites
- 0958US2019160069A1Pharmaceutical combinationsNOVARTIS AG·Filed 2019·Application pending·0 cites
- 1057US2017196866A1Intermittent dosing of mdm2 inhibitorNOVARTIS AG·Filed 2015·Application pending·0 cites
- 1156US2022031697A1Dose and regimen for an hdm2-p53 interaction inhibitor in hematological tumorsNOVARTIS AG·Filed 2021·Application pending·0 cites
- 1255US2016331751A1Pharmaceutical compositionsFERRETTI STEPHANE·Filed 2014·Application pending·0 cites
- 1354US2018015092A1Pharmaceutical combinationsNOVARTIS AG·Filed 2017·Application pending·0 cites
- 1452US2023293529A1Dosing regimens for n-((5-fluoro-2,3-dihydrobenzofuran-4-yl)methyl)-8-(2-methylpyridin-3-yl)-[1,2,4]triazolo[4,3-c]pyrimidin-5-amine, or a pharmaceutically acceptable salt thereof, for use in treating prc2-mediated diseases or disordersNOVARTIS AG·Filed 2021·Application pending·0 cites
- 1552US2017143723A1Pharmaceutical combinationsNOVARTIS AG·Filed 2017·Application pending·0 cites
- 1643US2021363254A1Pharmaceutical combinationsNOVARTIS AG·Filed 2019·Application pending·0 cites
- 1739US2016289770A1Markers associated with human double minute 2 inhibitorsGAULIS SWANN·Filed 2016·Application pending·0 cites
- 1835US2008261870A1Use of the Pro-Peptide Domain of Lysyl Oxidase as a Therapeutic AgentTRACKMAN PHILIP C·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Sebastien Jeay files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →